Investing
Top Analyst Upgrades & Downgrades (CERN, CNQR, RDY, ETN, GCA, HGSI, LLTC, OI, POM, SWI, WFC, XLNX)
Published:
These are some of the top analyst upgrades and downgrades seen in Wall Street research calls this Thursday morning:
Cerner Corp. (NASDAQ: CERN) Raised to Buy at Jefferies.
Concur Technologies (NASDAQ: CNQR) Raised to Buy at Jefferies.
Dr Reddy’s (NYSE: RDY) Cut to Equal-weight at Morgan Stanley
Eaton Corp (NYSE: ETN) Raised to Outperform at Wells Fargo.
Global Cash Access Holdings (NYSE: GCA) Cut to Neutral at Sterne Agee.
Human Genome Sciences (NASDAQ: HGSI) Raised to Outperform at Baird.
Linear Technology Corp. (NASDAQ: LLTC) Reiterated Buy but Raised target to $40 at Gleacher.
Owens-Illinois (NYSE: OI) Cut to Neutral at Goldman Sachs.
Pepco Holdings (NYSE: POM) Raised to Neutral at JPMorgan.
SolarWinds (NYSE: SWI) Cut to Hold at Needham; Cut to Hold at Jefferies; Goldman Sachs cut to Neutral.
Wells Fargo & Co. (NYSE: WFC) Raised to Outperform at FBR.
Xilinx (NASDAQ: XLNX) Reiterated Buy and Raised target to $33 at Gleacher.
JON C. OGG
Robinhood set out to democratize investing to individuals, and it’s not slowing down. The app makes it possible to buy and sell stocks, mutual funds, trade options, and even cryptocurrencies like Bitcoin (BTC) and Ethereum (ETH).
With FDIC insurance ,an award winning design, and benefits like IRAs and more, Robinhood could be your path to a richer tomorrow.
Sign up today — click here to start your journey.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.